Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER_GOV 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 11Breast 11Gastrointestinal 9Head & Neck 4Thoracic 3Gynecologic 3Other solid neoplasm 2CNS 2Tumor-Agnostic 1Lymphoid 1Dermatologic 1

Conditions

Brain Neoplasms 2Hemangioma, Capillary 1Cerebral Hemorrhage 1Arteriovenous Malformations 1

Interventions

Temozolomide 610Radiotherapy 387Bevacizumab 253Magnetic Resonance Spectroscopy 202Cyclophosphamide 177Carboplatin 159Radiosurgery 145Etoposide 132Radiation 120Irinotecan 115Vincristine 114Cisplatin 102Filgrastim 100Specimen Handling 88Nivolumab 87pembrolizumab 81Lomustine 80Topotecan 73Surgical Procedures, Operative 73Doxorubicin 60Melphalan 59Carmustine 57sargramostim 53Radiotherapy, Intensity-Modulated 53Isotretinoin 53Peripheral Blood Stem Cell Transplantation 52Granulocyte Colony-Stimulating Factor 50Erlotinib Hydrochloride 50Everolimus 48Chemotherapy, Adjuvant 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Ultrasonography × CNS × Clear all
NCT02656407 2025-09-02

FUSIMAGINE

Institut National de la Santé Et de la Recherche Médicale, France

Phase NA Completed
23 enrolled
CNS

Brain Neoplasms

NCT05484245 2025-05-16

SOMALI

Sklifosovsky Institute of Emergency Care

Phase NA Recruiting
100 enrolled
CNS

Arteriovenous Malformations, Brain Neoplasms, Cerebral Hemorrhage, Hemangioma, Capillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡